What does Medicus Pharma do?

Medicus Pharma Ltd. is a clinical-stage biotech company based in Toronto, Canada. Founded in 2008, it focuses on identifying and developing innovative therapeutic assets. The company aims to advance clinical-stage programs through Phase 2 proof-of-concept studies, generating data for potential licensing and partnerships with established pharmaceutical companies. Medicus operates across multiple countries and emphasizes addressing unmet medical needs in healthcare. The company has two main programs: SkinJect, a non-invasive microneedle patch for delivering chemotherapy directly to basal cell carcinoma tumors, and Teverelix, a next-generation GnRH antagonist for testosterone suppression in patients with advanced prostate cancer. Both programs are in clinical development, targeting significant market opportunities in dermatology and oncology. Medicus Pharma is committed to enhancing patient safety and efficacy through its innovative approaches and strategic partnerships.